Cargando…

Pegylated Liposomal Doxorubicin and Kidney-Limited Thrombotic Microangiopathy in a Kidney Transplant Recipient: A Case Report

A 64-year-old man with Kaposi sarcoma in clinical remission after treatment with pegylated liposomal doxorubicin and a history of deceased-donor kidney transplantation 4 years prior presented with a slowly progressive increase in his serum creatinine level, well-controlled hypertension, stable subne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodriguez-Ramirez, Sonia, Yau, Kevin, Kitchlu, Abhijat, John, Rohan, Rose, April A.N., Hogg, David, Kim, S. Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058600/ https://www.ncbi.nlm.nih.gov/pubmed/35509676 http://dx.doi.org/10.1016/j.xkme.2022.100461

Ejemplares similares

Thrombotic Microangiopathy Associated with Pazopanib in a Kidney Transplant Recipient
por: Kalla, Shabana, et al.
Publicado: (2021)

Pegylated liposomal doxorubicin in ovarian cancer
por: Green, Andrew E, et al.
Publicado: (2006)

Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2020)

Characteristics and management of thrombotic microangiopathy in kidney transplantation
por: Cho, Wonyong, et al.
Publicado: (2023)

Progressive multifocal cerebral infarction in a young kidney transplant recipient due to thrombotic microangiopathy
por: Haghikia, Arash, et al.
Publicado: (2014)

Pegylated liposomal doxorubicin in ovarian cancer
por: Strother, Robert, et al.
Publicado: (2009)

Pegylated liposomal doxorubicin for myeloid neoplasms
por: Zhang, Cheng, et al.
Publicado: (2019)

Biopsy-Proven Renal-Limited Thrombotic Microangiopathy in a Heart Transplant Recipient
por: Bharati, Joyita, et al.
Publicado: (2023)

Immunotherapy in oncology and the kidneys: a clinical review of the evaluation and management of kidney immune-related adverse events
por: Rao Ullur, Avinash, et al.
Publicado: (2023)

Primary Hyperaldosteronism: A Rare Cause of Malignant Hypertension with Thrombotic Microangiopathy in a Kidney Transplant Recipient
por: Ormonde, Carolina, et al.
Publicado: (2021)

MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy
por: Petr, Vojtech, et al.
Publicado: (2022)

Pegylated and liposomal doxorubicin is associated with high mortality and causes limited cardiotoxicity in mice
por: Stark, Christoffer, et al.
Publicado: (2018)

Thrombotic Microangiopathy in a Kidney Transplant Patient With COVID-19
por: Bascuñana, Arturo, et al.
Publicado: (2020)

Kidney thrombotic microangiopathy in lupus nephritis: Impact on treatment and prognosis
por: Massicotte-Azarniouch, David, et al.
Publicado: (2022)

Pegylated liposomal doxorubicin in the management of ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2010)

A tale of the two PEGylated liposomal doxorubicins
por: Chou, Hunghsueh, et al.
Publicado: (2015)

Effectiveness of Intravenous Immunoglobulin Plus Plasmapheresis on Antibody-mediated Rejection or Thrombotic Microangiopathy in Iranian Kidney Transplant Recipient
por: Dashti-Khavidaki, Simin, et al.
Publicado: (2015)

Malignant hypertension with thrombotic microangiopathy and persistent acute kidney injury (AKI)
por: Nzerue, Chike, et al.
Publicado: (2014)

Thrombotic Microangiopathy After Kidney Transplantation: An Underdiagnosed and Potentially Reversible Entity
por: Ávila, Ana, et al.
Publicado: (2021)

Vascular Occlusion in Kidney Biopsy Is Characteristic of Clinically Manifesting Thrombotic Microangiopathy
por: Kovala, Marja, et al.
Publicado: (2022)

Kidney-Predominant Thrombotic Microangiopathy Associated With TREX1 Frameshift Mutation
por: Song, Zhuo-ran, et al.
Publicado: (2023)

Acute allograft dysfunction mimicking thrombotic microangiopathy in kidney transplant recipient with renal infarction: case report and review of literatures
por: Lee, Sua, et al.
Publicado: (2020)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

Pegylated Liposomal Doxorubicin-induced Palmar-plantar Erythrodysesthesia
por: Moreira-Barros, Joana, et al.
Publicado: (2018)

Prolonged use of pegylated liposomal doxorubicin in gynecologic malignancies
por: Yost, S., et al.
Publicado: (2019)

Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
por: Yuan, Zhen, et al.
Publicado: (2021)

Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma
por: Ghaferi, Mohsen, et al.
Publicado: (2022)

Modeling pegylated liposomal doxorubicin-induced hand-foot syndrome and intestinal mucositis in zebrafish
por: Chen, Yau-Hung, et al.
Publicado: (2014)

Osmotic Tubulopathy and Acute Thrombotic Microangiopathy in a Kidney Transplant Recipient With a Breakthrough SARS-CoV-2 Infection
por: Fahim, Peter, et al.
Publicado: (2022)

Acute kidney injury induced by thrombotic microangiopathy in a patient with hemophagocytic lymphohistiocytosis
por: Bae, Myoung Nam, et al.
Publicado: (2016)

Thrombotic Microangiopathy Causing Acute Kidney Injury in a COVID-19 Patient
por: Kulkarni, Amitabh, et al.
Publicado: (2021)

Thrombotic microangiopathies after kidney transplantation in modern era: nosology based on chronology
por: Von Tokarski, Florent, et al.
Publicado: (2023)

Chronic kidney disease, survival and graft-versus-host-disease-free/relapse-free survival in recipients of allogeneic hematopoietic stem cell transplant
por: Pelletier, Karyne, et al.
Publicado: (2022)

Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi’s sarcoma
por: Udhrain, Ashish, et al.
Publicado: (2007)

Clinical Trials with Pegylated Liposomal Doxorubicin in the Treatment of Ovarian Cancer
por: Pisano, Carmela, et al.
Publicado: (2013)

Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer: The APPROVE Randomized Clinical Trial
por: Wang, Tiantian, et al.
Publicado: (2022)

Thrombotic microangiopathy in children
por: Palma, Lilian Monteiro P., et al.
Publicado: (2022)

Thrombotic Microangiopathy: An Under-Recognised Cause of Snake-bite-related Acute Kidney Injury
por: Rao, Indu Ramachandra, et al.
Publicado: (2019)

Clinical and pathological features of thrombotic microangiopathy influencing long-term kidney transplant outcomes
por: Teixeira, Cínthia Montenegro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s5dqfo0mntgtsicuc7miahv3mk